Page 32 - Gates-AnnualReport-2018

PAST GATES GRUBSTAKE FUND AWARDEES
2014
• Xiao-Jing Wang, M.D., Ph.D.: Human Smad7-based proteins combined with a cell permeable peptide called Tat. Tat- Smad7 and its derivatives can be used via topical application to treat at least four diseases: oral mucositis, psoriasis, chronic wounds, and fibrotic diseases.
• Antonio Jimeno, M.D., Ph.D.: Proprietary humanized mouse model to assess cancer treatments
2015
• Ganna Bilousova, Ph.D., and Igor Kogut, Ph.D.: Induced pluripotent stem cell services as a platform for clinical research
• Steven Dow, DVM, Ph.D., and Mary Ann DeGroote, M.D.: Antimicrobial stem cell therapy for infected diabetic foot ulcers
• Karin Payne, Ph.D., and Vikas Patel, M.D.: Structural living bone allografts to enhance bone formation in orthopedic
surgery
2016
• Jeffrey Olsen, M.D.: Intraocular device to potentiate retinal stem cell transplantation in macular degeneration
• Ken Liechty, M.D.: A platform technology useful for treating a variety of diseases where inflammation and oxidative stress are pathognomonic in the progression of the disease; initial focus is treatment of diabetic ulcers, where compelling in vitro and animal model data exists showing that treatment results in closure rates of diabetic wounds equal to
nondiabetic wounds
• David Wagner, Ph.D.: A 15-amino acid peptide to potentially stop demyelination and restore myelin production in
multiple sclerosis
2017
• Karin Payne, Ph.D.: Bioresorbable 3-D printed personalized implant for cartilage regeneration in pediatric growth plate injuries
• Valeria Canto-Soler, Ph.D.: Stem cell-derived retinal transplant to treat dry-AMD
• Martin Zamora, Ph.D.: Clinical development of autologous CD117+ progenitor cell therapy for solid organ transplantation
CU Innovations Managing Director Kim Muller
32 Gates Center for Regenerative Medicine
2017 Grubstake Fund awardee Marty Zamora and colleague Robert Plenter